Treatments & Interventions
Topotecan hydrochloride
substance
Vinorelbine tartrate
substance
Topotecan
substance
Irinotecan
substance
Vinorelbine
substance
Irinotecan hydrochloride
substance
Docetaxel
substance
Gemcitabine
substance
Hydroxyurea
substance
Paclitaxel
substance
Gefitinib
substance
Pemetrexed
substance
Bevacizumab
substance
Gemcitabine hydrochloride
substance
Erlotinib
substance
Albumin bound paclitaxel
substance
Erlotinib hydrochloride
substance
Ceritinib
substance
Afatinib
substance
Afatinib dimaleate
substance
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 254637007
- UMLS CUI
- C0007131
- Fully Specified Name
- Non-small cell lung cancer (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 3
- Known Treatments
- 20
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.